Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Novo Nordisk A/S
Steering Committee Chair
Institute of Immunology and Immunotherapy, Professor of Experimental Hepatology and Honorary Consultant Hepatologist, Director of Research and Knowledge Transfer, College of Medical & Dental Sciences, Director of Centre for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, United Kingdom
Professor of Experimental Hepatology & Honorary Consultant Hepatologist, Translations & Clinical Research Institute Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdome
Professor, University of Turin, Torino, Italy
Director, NAFLD Research Center, Professor of Medicine, Director of Hepatology Division of Gastroenterology, Adjunct Professor, Division of Epidemiology, University of California San Diego, San Diego, California, United States
Professor, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States
Professor of Hepatology, Chief of the Liver Diseases Department, Hautepierre Hospital, University of Strasbourg, Strasbourg, France
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Boehringer Ingelheim; Bristol Myers Squibb; Gilead; Novo Nordisk; Pfizer; Poxel
Served as a speaker or a member of a speakers bureau for: Gilead; NovoNordisk
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: 89Bio; Abbott Laboratories; Acuitas Medical; Allergan/Tobira; Altimmune; AstraZeneca; Axcella; Blade; Bristol Myers Squibb; BNN Cardio; Celgene; Cirius; Clinical Care Options; CymaBay; EcoRl; E3Bio; Eli Lilly & Company Ltd.; Falk; Fishawack; Galmed; Genentech; Genfit SA; Gilead; Grunthal; Histolndex; lndalo; Imperial Innovations; lntegritas Communications; Intercept Pharma Europe Ltd.; lnventiva; IQVIA; Janssen; Kenes; Madrigal; Medlmmune; Metacrine; NewGene; NGMBio; North Sea Therapeutics; Novartis; Novo Nordisk A/S; Pfizer Ltd.; Poxel; ProSciento; Raptor Pharma; Servier; Terns; Viking Therapeutics
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Allergan/Tobira; Bristol Myers Squibb; Clinical Care Options; Falk; Fishawack; Genfit SA; Gilead; lntegritas Communications; Kenes
Received grants for clinical research from: Abbvie; Antaros Medical; Allergan/Tobira; AstraZeneca; Bristol Myers Squibb; Boehringer lngelheim International GMBH; Echosens; Ellegaard Gottingen Minipigs AS; Eli Lilly & Company Ltd.; Exalenz Bioscience Ltd.*; Genfit SA*; Glympse Bio; GlaxoSmithKline; Histolndex*; Intercept Pharma Europe Ltd.; iXscient Ltd.; Nordic Bioscience; Novartis Pharma AG; Novo Nordisk A/S; One Way Liver Genomics SL; Perspectum Diagnostics; Pfizer Ltd.; Resoundant; Sanofi-Aventis Deutsch land GMBH; SomaLogic Inc.; Takeda Pharmaceuticals International SA
Other: Royalties from Elsevier Ltd
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bristol Myers Squibb; Boehringer Ingelheim; Gilead; Intercept; Novo Nordisk
Served as a speaker or a member of a speakers bureau for: Gilead; Intercept
Received grants for clinical research from: Gilead
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Anylam/Regeneron; Amgen; Arrowhead Pharmaceuticals; AstraZeneca; Bristol Myers Squibb; Eli Lilly; Galmed; Gilead; Intercept; Ionis; Janssen Inc.; Merck; Metacrine Inc.; NGM Biopharmace
Other: Co-founder of Liponexus
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Bristol Myers Squibb; Boehringer-Ingelheim; Celgene; Gilead; Intercept; Inventiva; Madrigal; Malinckrodt; Merck; NGM; Novo Nordisk; Lilly; Pfizer; Viking; Zydus
Received grants for clinical research from: Durect; Exhalenz; Genfit; Hemoshear; Indalo
Owns stock, stock options, or bonds from: Sanyal Bio
Other: Royalties from Elsevier and Uptodate
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alnylam Pharmaceuticals; Intercept; Novartis; NovoNordisk; Pfeizer; Theratechnology
Served as a speaker or a member of a speakers bureau for: Gilead; Intercept; Novartis/Sandoz
Received grants for clinical research from: Gilead
